Pathology Department, University of California, San Francisco, CA, USA.
Pathology Department, El Camino Hospital, Mountain View, CA, USA.
Histopathology. 2020 Jul;77(1):100-111. doi: 10.1111/his.14069. Epub 2020 Jun 12.
A unique fibrosarcoma-like tumour of the uterine cervix harbouring a rearrangement of a neurotrophic tyrosine kinase receptor (NTRK) gene (NTRK1 or NTRK3) has recently been described in 11 young women, some with recurrence and/or metastasis. The aims of this study were to expand the morphological spectrum of this tumour by reporting three additional cases that showed adenosarcoma-like features not previously described, one of which is the first reported to respond to targeted therapy, and to evaluate 19 conventional uterine adenosarcomas for evidence of NTRK rearrangement.
Three patients presented with a polyp or mass confined to the cervix. The constellation of polypoid growth, spindle cell morphology, entrapped endocervical glands and intraglandular stromal projections raised diagnostic consideration for adenosarcoma with stromal overgrowth. Deep cervical wall invasion was present in two cases at hysterectomy, and the third was removed by polypectomy. All three stained for S100 and pan-Trk, but were negative for a spectrum of other diagnostic markers. All three harboured NTRK rearrangements (TPM3-NTRK1, TPR-NTRK1, and SPECC1L-NTRK3). One patient developed pleural metastases at 16 months, received the NTRK inhibitor larotrectinib, and is free of disease 15 months later. Two others are alive without disease. None of the uterine adenosarcomas showed any S100 or pan-Trk staining, or rearrangement of NTRK1, NTRK2 or NTRK3 on next-generation sequencing.
Unusual adenosarcoma-like spindle cell neoplasms of the cervix may represent an NTRK fusion sarcoma, which can be detected by S100 and pan-Trk staining and confirmed by NTRK molecular testing. Conventional uterine adenosarcomas do not harbour NTRK rearrangements.
最近在 11 名年轻女性中描述了一种独特的宫颈纤维肉瘤样肿瘤,其具有神经生长因子受体(NTRK)基因(NTRK1 或 NTRK3)的重排。本研究的目的是通过报告另外三个以前未描述的具有腺肉瘤样特征的病例来扩大该肿瘤的形态谱,其中一个是第一个报道对靶向治疗有反应的病例,并评估 19 例常规子宫腺肉瘤是否存在 NTRK 重排的证据。
三名患者表现为局限于宫颈的息肉或肿块。息肉状生长、梭形细胞形态、被捕获的宫颈内膜腺体和腺体内间质突起的组合引起了腺肉瘤伴间质过度生长的诊断考虑。两例在子宫切除术时有深部宫颈壁浸润,第三例通过息肉切除术切除。所有三例均对 S100 和泛 Trk 染色,但对一系列其他诊断标志物均为阴性。所有三例均存在 NTRK 重排(TPM3-NTRK1、TPR-NTRK1 和 SPECC1L-NTRK3)。一名患者在 16 个月时出现胸膜转移,接受了 NTRK 抑制剂拉罗替尼治疗,15 个月后疾病无进展。另外两名患者仍无疾病。没有一例子宫腺肉瘤显示任何 S100 或泛 Trk 染色,或下一代测序显示 NTRK1、NTRK2 或 NTRK3 的重排。
宫颈不典型腺肉瘤样梭形细胞肿瘤可能代表 NTRK 融合肉瘤,可通过 S100 和泛 Trk 染色检测,并通过 NTRK 分子检测证实。常规子宫腺肉瘤不具有 NTRK 重排。